Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Ohio State University
mi
from
Columbus, OH
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Texas Medical Center - St. Paul University
mi
from
Dallas, TX
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Texas Medical Center - St. Paul University
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Baylor College of Medicine/The Methodist Hospital
mi
from
Houston, TX
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Baylor College of Medicine/The Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Dept. of Pulmonary Medicine - Latter Day Saints Hospital
mi
from
Salt Lake City, UT
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Dept. of Pulmonary Medicine - Latter Day Saints Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Sentara Hospital T/A Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Sentara Hospital T/A Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Comprehensive Cardiovascular Care Group
mi
from
Milwaukee, WI
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Comprehensive Cardiovascular Care Group
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Fundacion Favaloro
mi
from
Buenos Aires,
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Fundacion Favaloro
mi
from
Buenos Aires,
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UCSD Medical Center
mi
from
La Jolla, CA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA
mi
from
Torrance, CA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Lung Health and Sleep Enhancement Center
mi
from
Newark, DE
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Lung Health and Sleep Enhancement Center
mi
from
Newark, DE
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Florida
mi
from
Gainesville, FL
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Mercy Hospital
mi
from
Iowa City, IA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Mercy Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Lsu Health Sciences Center
mi
from
New Orleans, LA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Lsu Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Winthrop University Hospital
mi
from
Mineola, NY
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Legacy Health System
mi
from
Portland, OR
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Legacy Health System
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Temple University Hospital
mi
from
Philadelphia, PA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Rhode Island Hospital
mi
from
Providence, RI
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Lexington Pulmonary and Critical Care
mi
from
Lexington, SC
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Lexington Pulmonary and Critical Care
mi
from
Lexington, SC
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UT Southwestern Medical Center Heart Lung and Vacular Center
mi
from
Dallas, TX
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UT Southwestern Medical Center Heart Lung and Vacular Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Texas Medical School
mi
from
Houston, TX
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Texas Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Central Utah Clinic
mi
from
American Fork, UT
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Central Utah Clinic
mi
from
American Fork, UT
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Intermountain Medical Center
mi
from
Murray, UT
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Virginia
mi
from
Charlottesville, VA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Sentara Hospitals T/A Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Sentara Hospitals T/A Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Spokane Respiratory Consultants
mi
from
Spokane, WA
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Spokane Respiratory Consultants
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UW Hospital and Clinics
mi
from
Madison, WI
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UW Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Comprehensive Cardiovascular Care LLP
mi
from
Milwaukee, WI
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Comprehensive Cardiovascular Care LLP
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
LHK Universitatsklinikum Graz
mi
from
Graz,
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
LHK Universitatsklinikum Graz
mi
from
Graz,
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UCSD Medical Center
mi
from
La Jolla, CA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA
mi
from
Torrance, CA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA
mi
from
Torrance, CA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Lung Health and Sleep Enhancement Center
mi
from
Newark, DE
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Lung Health and Sleep Enhancement Center
mi
from
Newark, DE
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Florida
mi
from
Gainesville, FL
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/10/2015
Mercy Hospital
mi
from
Iowa City, IA
Iloprost Power 15 in Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/10/2015
Mercy Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials